FDAnews Drug Daily Bulletin

Catalyst Pharmaceutical Partners Provides Update on Research and Development Pipeline

Feb. 12, 2013
A A
Catalyst Pharmaceutical, a specialty pharmaceutical company focused on the development and commercialization of novel prescription drugs targeting rare (orphan) neurological diseases and disorders, today provided an update on its research and development pipeline.
GlobeNewswire